CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge

It remains a challenge to develop a successful human immunodeficiency virus (HIV) vaccine that is capable of preventing infection. Here, we utilized the benefits of CD40L, a costimulatory molecule that can stimulate both dendritic cells (DCs) and B cells, as an adjuvant for our simian immunodeficien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kwa, Suefen, Lai, Lilin, Gangadhara, Sailaja, Siddiqui, Mariam, Pillai, Vinod B., Labranche, Celia, Yu, Tianwei, Moss, Bernard, Montefiori, David C., Robinson, Harriet L., Kozlowski, Pamela A., Amara, Rama Rao
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136340/
https://ncbi.nlm.nih.gov/pubmed/24920805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00975-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars